Skip to content
10-Q

Quarterly Report

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

0001193125-22-281196

← back to feed
Filed
Nov 9, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$806.17K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$11.67M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$6.18M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$4.97M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$6.36M
Current Liabilities Q3 2022 · Sep 30, 2022 $3.81M
Current Liabilities Q3 2022 · Dec 31, 2021 $222.07K
Total Liabilities Q3 2022 · Sep 30, 2022 $12.21M
Total Liabilities Q3 2022 · Dec 31, 2021 $7.86M
Current Assets Q3 2022 · Sep 30, 2022 $444.76K
Current Assets Q3 2022 · Dec 31, 2021 $1.49M
Total Assets Q3 2022 · Sep 30, 2022 $139.28M
Total Assets Q3 2022 · Dec 31, 2021 $139.51M
Sga Expense Q3 2022 · Sep 30, 2022 $2.26M
Sga Expense Q3 2022 · Sep 30, 2022 $4.54M
Net Income Q3 2022 · Sep 30, 2022 −$4.78M
Net Income Q3 2022 · Sep 30, 2022 −$4.57M
Net Income Q3 2022 · Jun 30, 2022 −$1.17M
Net Income Q3 2022 · Mar 31, 2022 $1.38M
Operating Income Q3 2022 · Sep 30, 2022 −$2.29M
Operating Income Q3 2022 · Sep 30, 2022 −$4.63M